Nanobiotix S.A. (NASDAQ:NBTX) shares are up on Wednesday as the company responds to recent media speculation regarding potential acquisition intentions.

The stock's movement follows a statement clarifying that there is no ongoing process or assessment for a takeover, which has helped to stabilize investor sentiment as broader markets are experiencing gains.

Earlier on Wednesday, reports in the media outlet La Lettre indicated potential interest from Johnson & Johnson (NYSE:JNJ).

NBTX Denies Takeover Talks Amid Reports

In a recent statement, Nanobiotix emphasized that it has identified factual inaccuracies in media reports suggesting a potential acquisition. The company reassured investors that it is not pursuing any control changes and remains focused on its innovative therapeutic approaches in biotechnology.

Additionally, Nanobiotix is a late-stage ...